Restoration of Promyelocytic Leukemia Protein-Nuclear Bodies in Neuroblastoma Cells Enhances Retinoic Acid Responsiveness

Cancer Research

Volumn 64, Issue 3, 2004, Pages 928-933

  Yu, Jiang Hong ^a   Nakajima, Ayako ^a   Nakajima, Hiroshi ^a   Diller, Lisa R ^b,c   Bloch, Kenneth D ^a   Bloch, Donald B ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; GAMMA INTERFERON; PROMYELOCYTIC LEUKEMIA PROTEIN; RETINOIC ACID;

ARTICLE; BONE MARROW CELL; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL NUCLEUS INCLUSION BODY; CELL STRUCTURE; CONTROLLED STUDY; DRUG EFFICACY; EMBRYO CELL; HUMAN; HUMAN CELL; NEURAL CREST CELL; NEUROBLAST; NEUROBLASTOMA; NEUROBLASTOMA CELL; PATHOGENESIS; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; SOLID TUMOR; TISSUE SECTION;

ANTINEOPLASTIC AGENTS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL NUCLEUS STRUCTURES; HL-60 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM PROTEINS; NEUROBLASTOMA; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS; TRETINOIN; TUMOR SUPPRESSOR PROTEINS;

EID: 0842325799     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-1199     Document Type: Article

References (29)

1. Rettig, W. J., Spengler, B. A., Chesa, P. G., Old, L. J., and Biedler, J. L. Coordinate changes in neuronal phenotype and surface antigen expression in human neuroblastoma cell variants. Cancer Res., 47: 1383-1389, 1987.
2. Ross, R. A., Spengler, B. A., and Biedler, J. L. Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J. Natl. Cancer Inst. (Bethesda), 71: 741-747, 1983.
3. Ross, R. A., Spengler, B. A., Domenech, C., Porubcin, M., Rettig, W. J., and Biedler, J. L. Human neuroblastoma I-type cells are malignant neural crest stem cells. Cell Growth Differ., 6: 449-456, 1995.
4. Seeler, J. S., and Dejean, A. The PML nuclear bodies: actors or extras? Curr. Opin. Genet. Dev., 9: 362-367, 1999.
5. Ruggero, D., Wang, Z. G., and Pandolfi, P. P. The puzzling multiple lives of PML and its role in the genesis of cancer. Bioessays, 22: 827-835, 2000.
6. Zhong, S., Salomoni, P., and Pandolfi, P. P. The transcriptional role of PML and the nuclear body. Nat. Cell Biol., 2: E85-E90, 2000.
7. Melnick, A., and Licht, J. D. Deconstructing a disease: RARα, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood, 93: 3167-3215, 1999.
8. Ishov, A. M., Sotnikov, A. G., Negorev, D., Vladimirova, O. V., Neff, N., Kamitani, T., Yeh, E. T., Strauss, J. F., and Maul, G. G. PML is critical for ND10 formation and recruits the PML-interacting protein Daxx to this nuclear structure when modified by SUMO. J. Cell Biol., 147: 221-234, 1999.
9. Zhong, S., Muller, S., Ronchetti, S., Freemont, P. S., Dejean, A., and Pandolfi, P. P. Role of SUMO-1-modified PML in nuclear body formation. Blood, 95: 2748-2752, 2000.
10. Wang, Z. G., Delva, L., Gaboli, M., Rivi, R., Giorgio, M., Cordon-Cardo, C., Grosveld, F., and Pandolfi, P. P. Role of PML in cell growth and the retinoic acid pathway. Science (Wash. DC), 279: 1547-1551, 1998.
11. Lanotte, M., Matrin-Thouvenin, V., Najman, S., Balerini, P., Valensi, F., and Berger, R. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood, 77: 1080-1086, 1991.
12. Negorev, D., Ishov, A. M., and Maul, G. G. Evidence for separate ND10-binding and homo-oligomerization domains of Sp100. J. Cell Sci., 114: 59-68, 2001.
13. Li, H., Leo, C., Zhu, J., Wu, X., O'Neil, J., Park, E. J., and Chen, J. D. Sequestration and inhibition of Daxx-mediated transcriptional repression by PML. Mol. Cell Biol., 20: 1784-1796, 2000.
14. de Thé, H., Chomienne, C., Lanotte, M., Degos, L., and Dejean, A. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locus. Nature (Lond.), 347: 558-561, 1990.
15. Bloch, D. B., Chiche, J. D., Orth, D., de la Monte, S. M., Rosenzweig, A., and Bloch, K. D. Structural and functional heterogeneity of nuclear bodies. Mol. Cell Biol., 19: 4423-4430, 1999.
16. Graham, F. L., and Preyec, L. Manipulation of adenovirus vectors, pp. 109-128. Clifton, NJ: Humana Press, 1991.
17. He, T. C., Zhou, S., da Costa, L. T., Yu, J., Kinzler, K. W., and Vogelstein, B. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA, 95: 2509-2514, 1998.
18. Sambrook, J., Fritsh, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory 1989.
19. Bloch, D. B., Nakajima, A., Gulick, T., Chiche, J. D., Orth, D., de La Monte, S. M., and Bloch, K. D. Sp110 localizes to the PML-Sp100 nuclear body and may function as a nuclear hormone receptor transcriptional coactivator. Mol. Cell Biol., 20: 6138-6146, 2000.
20. Alam, J., and Cook, J. L. Reporter genes: application to the study of mammalian gene transcription. Anal. Biochem., 188: 245-254, 1990.
21. Parodi, M. T., Cornaglia-Ferraris, P., and Ponzoni, M. Effects of γ-interferon on the growth, morphology, and membrane and cytoskeletal proteins expression of LAN-1 cells. Exp. Cell Res., 185: 327-341, 1989.
22. Calleja, E. M., and Warrell, R. P. Differentiating agents in pediatric malignancies: all-trans retinoic acid and arsenic in acute promyelocytic leukemia. Curr. Oncol. Rep., 2: 519-523, 2000.
23. Dombret, H., Fenaux, P., Soignet, S. L., and Tallman, M. S. Established practice in the treatment of patients with acute promyelocytic leukemia and the introduction of arsenic trioxide as a novel therapy. Semin. Hematol., 39: 8-13, 2002.
24. Matthay, K. K., Villablanca, J. G., Seeger, R. C., Stram, D. O., Harris, R. E., Ramsay, N. K., Swift, P., Shimada, H., Black, C. T., Brodeur, G. M., Gerbing, R. B., and Reynolds, C. P. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis retinoic acid, Children's Cancer Group. N. Engl. J. Med., 341: 1165-1173, 1999.
25. Doucas, V., Tini, M., Egan, D. A., and Evans, R. M. Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling. Proc. Natl. Acad. Sci. USA, 96: 2627-2632, 1999.
26. Zhong, S., Delva, L., Rachez, C., Cenciarelli, C., Gandini, D., Zhang, H., Kalantry, S., Freedman, L. P., and Pandolfi, P. P. A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARα and T18 oncoproteins. Nat. Genet., 23: 287-295, 1999.
27. Wuarin, L., Verity, M. A., and Sidell, N. Effects of interferon γ and its interaction with retinoic acid on human neuroblastoma differentiation. Int. J. Cancer, 48: 136-141, 1991.
28. Guzhova, I., Hultquist, A., Cetinkaya, C., Nilsson, K., Pahlman, S., and Larsson, L. G. Interferon γ cooperates with retinoic acid and phorbol ester to induce differentiation and growth inhibition of human neuroblastoma cells. Int. J. Cancer, 94: 97-108, 2001.
29. Yu, E., Choi, E., and Kim, C. J. Expression of promyelocytic leukemia protein increases during differentiation of human neuroblastoma cells. Virch. Arch., 442: 278-283, 2003.